South Bay Pathology Society
DIAGNOSES
FOR THE MEETING OF MONDAY, 1/8/07
DIAGNOSTIC TALLY
Metastatic clear cell carcinoma.................2
Adenocarcinoma-........................................2
Psammomatous carcinoma, micropapillary type.....................................8
metastatic ovarian serous ca.....................16
SB-5021 Stromal and Lymphovascular Invasion by Ovarian Carcinoma, Cervix
Note: The site of origin of the tumor appears to be the surface of the ovaries. The tumor also involves the uterus, peritoneum, omentum and lymph nodes.
Follow-up: This is a recent case with only very short follow up.
DIAGNOSTIC TALLY
Sertoli cell tumor w/ thyroid like areas..............................................................2
Brenner tumor...........................................12
Struma ovarii w/ adenofibroma.................2
SB-5022 Struma Ovarii and Brenner Tumor, Ovary.
Follow-up: The patient expired of mesenteric ischemia.
SB-5023 Mixed Tumor, Probably Benign, Soft Tissue, Right Foot.
DIAGNOSTIC TALLY
Eccrine carcinoma....................................4
Atypical mixed tumor..............................1
Glomus tumor............................................4
Mixed tumor.............................................24
Note: The tumor cells are positive for AE 1/3, S 100 and Calponin; SMA, p63 and GFAP are negative.
Consultant: Sharon Weiss, M.D.
DIAGNOSTIC TALLY
Myiasis.........................................................4
Dracunculiasis............................................2
Gnathostomiasis..........................................1
SB-5024 Furuncular Myiasis, Posterior Scalp.
Note: The submitted slides were of the breathing tubes.
Follow-up: The patient is currently well.
DIAGNOSTIC TALLY
Large cell lymphoma................................3
Benign, viral/reactive changes................4
SB-5025 Mantle Cell Lymphoma, Mantle Zone Pattern, with an Unusual Interfollicular Mixed Inflammatory Infiltrate, Right Cervical Lymph Node.
Follow-up: This is a recent case with only short follow.
Note: C5, CD 20 and BCL-1 are positive in mantle zones. There is no T cell clonality. EBV ISH is neg.
Reference: 1. J Clin Oncol 15: 1664-71, 1997.
2. Br. J Haematol. 131(1): 29-38, 2005.
DIAGNOSTIC TALLY
Fibrous meningioma arising in Meningoangiomatosis..........................52
SB-5026 Malignant Meningioma, WHO Grade II with Neural Parenchymal Invasion, Right Tentorial Tumor.
Follow-up: The patient has not done well and has had recurrences.
Note: EMA is negative. GFAP is positive in surrounding brain tissue and negative in the tumor.
Reference: Neurosurg. 86(5): 793-800, 1997.
DIAGNOSTIC TALLY
Fibromatosis ..............................................2
Low grade myxoid sarcoma..................4
Schwannoma...............................................6
Myofibroblastic/inflammatory lesion....4
SB-5027 Monophasic Synovial Sarcoma, Right Parapharyngeal Space Mass.
Follow-up: This is a recent case with a short follow up.
Note: S 100, SMA and MSA (HHF35) are negative. FISH analysis shows the characteristic [t(X;18)] SYG gene rearrangement.
Reference: Weiss, SR, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors, 4th edition, page 1484.
DIAGNOSTIC TALLY
Sarcoma NOS........................Unanimous
SB-5028 Atypical Lipomatous Tumor (Well Differentiated Liposarcoma) Associated with Dedifferentiated Liposarcoma, Left Retroperitoneal Mass.
Note: CD 34 positive; keratin, vimentin, EMA, S100, actin, desmin and CD 117 negative.
SB-
DIAGNOSTIC TALLY
Papillary renal cell carcinoma..............46
Mucinous/tubular spindled carcinoma..4
5029 Mucinous and Tubular Spindled Carcinoma, Kidney
Note: Racemase diffusely positive.
Reference: AJSP 30: 1554, 2006.
DIAGNOSTIC TALLY
Nephrogenic fibrous dermatopathic changes........................................................2
Localized cutaneous nodular amyloidosis...............................................52
SB-5030 Nodular Amyloidosis, Vulva (Labia)
Post conference evaluation case: Mixed tumor, digit of foot.
Post conference evaluation case, December 2006: Polymorphous low-grade adenocarcinoma, palate.